Aktie 531015 VENMAX DRUGS AND PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Venmax Drugs and Pharmaceuticals Limited

Aktien

531015

INE154G01022

531015

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Venmax Drugs and Pharmaceuticals Limited Approves Resignation of Sadan Grover from the Post of Company Secretary & Compliance Officer
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Venmax Drugs and Pharmaceuticals Limited Announces Change in Management
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Venmax Drugs and Pharmaceuticals Limited Auditor Raises 'Going Concern' Doubt
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Venmax Drugs and Pharmaceuticals Limited Approves Shifting of Registered Office
Venmax Drugs and Pharmaceuticals Limited Proposes the Resignation of Shri Ramakrishnaiah Appanaboyana as Independent Director
Venmax Drugs and Pharmaceuticals Limited Announces Executive Changes
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 531015 Aktie
  4. Nachrichten Venmax Drugs and Pharmaceuticals Limited
  5. Andere Sprachen